JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M406440200 on November 30, 2004

J. Biol. Chem., Vol. 280, Issue 6, 4402-4414, February 11, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/6/4402    most recent
M406440200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arcuri, C.
Right arrow Articles by Donato, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arcuri, C.
Right arrow Articles by Donato, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

S100B Increases Proliferation in PC12 Neuronal Cells and Reduces Their Responsiveness to Nerve Growth Factor via Akt Activation*

Cataldo Arcuri, Roberta Bianchi, Flora Brozzi, and Rosario Donato{ddagger}

From the Section of Anatomy, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, 06122 Perugia, Italy

S100B is a Ca2+-modulated protein of the EF-hand type expressed in high abundance in a restricted set of cell types including certain neuronal populations. S100B has been suggested to participate in cell cycle progression, and S100B levels are high in tumor cells, compared with normal parental cells. We expressed S100B in the neuronal cell line PC12, which normally does not express the protein, by the Tet-Off technique, and found the following: (i) proliferation was higher in S100B+ PC12 cells than in S100B PC12 cells; (ii) nerve growth factor (NGF), which decreased the proliferation of S100B PC12 cells, was less effective in the case of S100B+ PC12 cells; (iii) expression of S100B made PC12 cells resistant to the differentiating effect of NGF; and (iv) interruption of S100B expression did not result in an immediate restoration of PC12 cell sensitivity to the differentiating effect of NGF. Expression of S100B in PC12 cells resulted in activation of Akt; increased levels of p21WAF1, an inhibitor of cyclin-dependent kinase (cdk) 2 and a positive regulator of cdk4; increased p21WAF1-cyclin D1 complex formation; and increased phosphorylation of the retinoblastoma suppressor protein, Rb. These S100B-induced effects, as well as the reduced ability of S100B+ PC12 cells to respond to NGF, were dependent on Akt activation because they were remarkably reduced or abrogated in the presence of LY294002, an inhibitor of the Akt upstream kinase phosphatidylinositol 3-kinase. Thus, S100B might promote cell proliferation and interfere with NGF-induced PC12 cell differentiation by stimulating a p21WAF1/cyclin D1/cdk4/Rb/E2F pathway in an Akt-mediated manner.


Received for publication, June 9, 2004 , and in revised form, November 29, 2004.

* This work was supported by Ministero dell'Istruzione, dell'Università e della Ricerca-University of Perugia (COFIN 1999), Fondo per gli Investimenti della Ricerca di Base (2001), and Fondazione Cassa di Risparmio di Perugia (Project 22202 and Project 2004.0282.020) funds to R. D. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Section of Anatomy, Dept. of Experimental Medicine and Biochemical Sciences, University of Perugia, Via del Giochetto Casella Postale 81 Succursale 3, 06122 Perugia, Italy. Tel.: 39-075-585-7453/7448; Fax: 39-075-585-7451; E-mail: donato{at}unipg.it.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
R. Bianchi, C. Adami, I. Giambanco, and R. Donato
S100B binding to RAGE in microglia stimulates COX-2 expression
J. Leukoc. Biol., January 1, 2007; 81(1): 108 - 118.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
O. I. Epstein, I. F. Pavlov, and M. B. Shtark
Improvement of Memory by Means of Ultra-Low Doses of Antibodies to S-100B Antigen
Evid. Based Complement. Altern. Med., December 1, 2006; 3(4): 541 - 545.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Cao, N. Dronadula, and G. N. Rao
Thrombin induces expression of FGF-2 via activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility in vascular smooth muscle cells
Am J Physiol Cell Physiol, January 1, 2006; 290(1): C172 - C182.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.